Compare NBTX & AMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NBTX | AMN |
|---|---|---|
| Founded | 2003 | 1985 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Assisted Living Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 2018 | 2001 |
| Metric | NBTX | AMN |
|---|---|---|
| Price | $32.60 | $37.94 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 9 |
| Target Price | ★ $54.24 | $44.79 |
| AVG Volume (30 Days) | 136.4K | ★ 991.0K |
| Earning Date | 09-24-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 35.58 |
| EPS | N/A | ★ 2.93 |
| Revenue | N/A | ★ $1,988,454,000.00 |
| Revenue This Year | N/A | $25.69 |
| Revenue Next Year | $50.69 | N/A |
| P/E Ratio | ★ N/A | $13.05 |
| Revenue Growth | N/A | ★ 4.53 |
| 52 Week Low | $19.14 | $14.97 |
| 52 Week High | $57.14 | $49.62 |
| Indicator | NBTX | AMN |
|---|---|---|
| Relative Strength Index (RSI) | 58.72 | 40.72 |
| Support Level | $30.73 | $31.48 |
| Resistance Level | $35.17 | $49.62 |
| Average True Range (ATR) | 1.84 | 2.54 |
| MACD | 0.56 | -1.38 |
| Stochastic Oscillator | 72.25 | 18.78 |
Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.
AMN Healthcare Services Inc provides healthcare workforce solutions and staffing services in the United States. Its comprehensive suite of talent solutions provides management, staffing, recruitment, language services, technology, predictive and market analytics, and related services to build and manage all or parts of the clients' healthcare workforce needs. Its reportable segments are: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. A majority of its revenue is generated from the Nurse and Allied Solutions segment, which includes the company's travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, and allied staffing (including revenue cycle solutions) businesses.